IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q4 2018 Holdings

Filed 2019-02-14 | 9 holdings | $162.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kalvista Pharmaceuticals Inc(KALV)COM483497103$50.3K2,548,20231.0%
Avrobio IncCOM05455M100$45.6K2,736,02728.0%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$27.0K1,287,22716.6%
Sutro Biopharma IncCOM869367102$16.5K1,824,54210.1%
Transenterix IncCOM NEW89366M201$15.0K6,631,8329.2%
Arsanis IncCOM042873109$4.3K1,868,9612.7%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.5K628,2361.5%
Catabasis Pharmaceuticals inCOM14875P107$1.2K285,7650.8%
Reshape Life Sciences IncCOM29365M505$01,0720.0%